Keyphrases
Oligodeoxynucleotide
100%
Bone Morphogenetic protein-7 (BMP-7)
100%
Microphysiological Systems
100%
Osteoarthritis
100%
Cartilage
100%
Joint Inflammation
100%
Combined Treatment
66%
Co-treatment
66%
Fibrous Tissue
66%
Nuclear factor-κB
66%
Joint Disease
66%
Osteochondral
66%
Interleukin-1β
33%
Clinical Trials
33%
Therapeutic Efficacy
33%
Adipose Tissue
33%
Clinically Significant
33%
Human Mesenchymal Stem Cells (hMSCs)
33%
Inflammation
33%
Novel Treatments
33%
Genetic Pathways
33%
Anti-inflammation
33%
Therapeutic Outcome
33%
Knee Joint
33%
Osteoarthritis Model
33%
Disease-modifying Osteoarthritis Drugs (DMOADs)
33%
Glycosaminoglycans
33%
Joint System
33%
Synovitis
33%
Cartilage Degeneration
33%
Tissue Analogs
33%
Model Limit
33%
Medicine and Dentistry
Osteoarthritis
100%
Arthritis
100%
Bone Morphogenetic Protein
60%
Oligodeoxynucleotide
60%
Arthropathy
40%
Nuclear Factor
40%
Disease
20%
Adipose Tissue
20%
Bone Marrow Derived Mesenchymal Stem Cell
20%
Clinical Trial
20%
Clinical Study
20%
Combination Therapy
20%
Interleukin 1
20%
Knee Joint
20%
Glycosaminoglycan
20%
Synovitis
20%
Cartilage Degeneration
20%
Pharmacology, Toxicology and Pharmaceutical Science
Osteoarthritis
100%
Arthritis
100%
Bone Morphogenetic Protein
60%
Oligodeoxynucleotide
60%
Nuclear Factor
40%
Arthropathy
40%
Interleukin 1
20%
Inflammation
20%
Disease
20%
Clinical Trial
20%
Clinical Study
20%
Combination Therapy
20%
Anti-Inflammation
20%
Glycosaminoglycan
20%
Synovitis
20%
Cartilage Degeneration
20%
Immunology and Microbiology
Arthritis
100%
Osteoarthritis
100%
Cartilage
100%
Bone Morphogenetic Protein
60%
Arthropathy
40%
Interleukin 1
20%
Adipose Tissue
20%
Bone Marrow Derived Mesenchymal Stem Cell
20%
Knee
20%
Synovitis
20%
Biochemistry, Genetics and Molecular Biology
Bone Morphogenetic Protein
100%
Clinical Trial
33%
Genetics
33%
Bone Marrow-Derived Mesenchymal Stem Cells
33%
Clinical Study
33%
Interleukin-1
33%
Glycosaminoglycan
33%